Peripheral Blood Stem Cell (PBSC) Haploidentical Transplantation Using a Reduced Intensity Conditioning (RIC), T Cell Replete Approach Proves Both Efficacious and Well Tolerated In a Range of Haematological Malignancies.
John A. Laurie(Guy's and St Thomas' NHS Foundation Trust), Kavita Raj(Johns Hopkins Hospital), Andrew Hodson(Ipswich Hospital), Claire John(St Thomas' Hospital), Matthew Streetly(King's College - North Carolina), Ophelia Manwaring(St Thomas' Hospital), Majid Kazmi, Carol M. Black, T Elston(St Thomas' Hospital)
Cited by 0
Related Papers
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
|The Lancet|2020|366
Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
|Journal of Clinical Oncology|2017|325
Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma
|Journal of Clinical Oncology|2004|315